RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
TGCNX
Price
$25.55
Change
+$0.01 (+0.04%)
Updated
Sep 5 closing price
Net Assets
740.73M
Interact to see
Advertisement

RGEBX vs TGCNX

Header iconRGEBX vs TGCNX Comparison
Open Charts RGEBX vs TGCNXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
TCW Concentrated Large Cap Growth N Cl
Price$25.55
Change+$0.01 (+0.04%)
VolumeN/A
Net Assets740.73M
RGEBX vs TGCNX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RGEBX vs. TGCNX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Buy and TGCNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. TGCNX (741M). RGEBX (0.00) and TGCNX (0.00) have matching dividends . RGEBX was incepted earlier than TGCNX: RGEBX (11 years) vs TGCNX (27 years). RGEBX (1.09) and TGCNX (1.06) have similar cost to investors . RGEBX is a more actively managed with annual turnover of: 25.00 vs. TGCNX (12.77). RGEBX has a lower initial minimum investment than TGCNX: RGEBX (250) vs TGCNX (2000). RGEBX annual gain was more profitable for investors over the last year : 17.32 vs. TGCNX (2.08). RGEBX return over 5 years is better than : 38.39 vs. TGCNX (-16.64).
RGEBXTGCNXRGEBX / TGCNX
Total Expense Ratio1.090.93117%
Annual Report Gross Expense Ratio1.091.06103%
Fund Existence11 years27 years-
Gain YTD15.13210.276147%
Front LoadN/AN/A-
Min. Initial Investment250200013%
Min. Initial Investment IRAN/AN/A-
Net Assets332B741M44,804%
Annual Yield % from dividends0.000.00-
Returns for 1 year17.322.08833%
Returns for 3 years57.2411.14514%
Returns for 5 years38.39-16.64-231%
Returns for 10 years91.00-3.26-2,793%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
ARCT17.851.09
+6.50%
Arcturus Therapeutics Holdings
MANH215.315.45
+2.60%
Manhattan Associates
TRMD23.020.25
+1.10%
TORM plc
INDP3.30-1.31
-28.35%
Indaptus Therapeutics Inc